Consequently, based on the survival data of the Kaplan-Meier plotter with Affymetrix 202911_at and 211449_at microarrays [26], we observed that the high expression of MSH6 was associated with poor prognosis of OS, RFS, PFS and DMFS prognosis in breast cancer cases. Here, MSH6 is linked to breast carcinoma.